J. Rassen

发表

Effects of adjusting for instrumental variables on bias and precision of effect estimates.

J. Myers, J. Rassen, J. Gagne, 2011, American journal of epidemiology.

Confounding Control in Healthcare Database Research: Challenges and Potential Approaches

J. Rassen, S. Schneeweiss, R. Glynn, 2010, Medical care.

High-dimensional Propensity Score Adjustment in Studies of Treatment Effects Using Health Care Claims Data

J. Avorn, J. Rassen, S. Schneeweiss, 2009, Epidemiology.

Simultaneously assessing intended and unintended treatment effects of multiple treatment options: a pragmatic “matrix design”

J. Rassen, S. Schneeweiss, R. Glynn, 2011, Pharmacoepidemiology and drug safety.

Covariate selection in high-dimensional propensity score analyses of treatment effects in small samples.

M Alan Brookhart, Jeremy A Rassen, Sebastian Schneeweiss, 2011, American journal of epidemiology.

Instrumental variables I: instrumental variables exploit natural variation in nonexperimental data to estimate causal relationships.

M Alan Brookhart, Jeremy A Rassen, Sebastian Schneeweiss, 2009, Journal of clinical epidemiology.

Instrumental variable methods in comparative safety and effectiveness research

Sebastian Schneeweiss, J. Rassen, S. Schneeweiss, 2010, Pharmacoepidemiology and drug safety.

Simultaneous assessment of short-term gastrointestinal benefits and cardiovascular risks of selective cyclooxygenase 2 inhibitors and nonselective nonsteroidal antiinflammatory drugs: an instrumental variable analysis.

M Alan Brookhart, Sebastian Schneeweiss, Daniel H Solomon, 2006, Arthritis and rheumatism.

KD-Tree Algorithm for Propensity Score Matching With Three or More Treatment Groups

J. Avorn, J. Rassen, J. Gagne, 2012 .

Instrumental variables II: instrumental variable application-in 25 variations, the physician prescribing preference generally was strong and reduced covariate imbalance.

M Alan Brookhart, Jeremy A Rassen, Sebastian Schneeweiss, 2009, Journal of clinical epidemiology.

Matching by Propensity Score in Cohort Studies with Three Treatment Groups

Jeremy A Rassen, Sebastian Schneeweiss, Daniel H Solomon, 2013, Epidemiology.

Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms

Miguel Correa Marrero, Robyn M. Kaake, Gwendolyn M. Jang, 2020, Science.

Validating Assisted Reproductive Technology Self-Report

J. Rassen, S. Schneeweiss, Shirley V. Wang, 2014 .

A modular, prospective, semi‐automated drug safety monitoring system for use in a distributed data environment

J. Rassen, J. Gagne, S. Schneeweiss, 2014, Pharmacoepidemiology and drug safety.

Emerging analytical techniques for comparative effectiveness research.

J. Rassen, S. Brunelli, 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Heart failure risk among patients with rheumatoid arthritis starting a TNF antagonist

J. Rassen, J. Lii, D. Solomon, 2012, Annals of the rheumatic diseases.

Empirical assessment of case‐based methods for drug safety alert identification in the French National Healthcare System database (SNDS): Methodology of the ALCAPONE project

J. Benichou, J. Rassen, J. Gagne, 2020, Pharmacoepidemiology and drug safety.

Categorization of COVID‐19 severity to determine mortality risk

J. Rassen, M. Bradley, N. Gatto, 2022, Pharmacoepidemiology and drug safety.

Cardiovascular risk in rheumatoid arthritis: comparing TNF-α blockade with nonbiologic DMARDs.

Mary K. Kowal, J. Rassen, J. Lii, 2013, The American journal of medicine.

Graphical Depiction of Longitudinal Study Designs in Health Care Databases

J. Rassen, S. Schneeweiss, G. D. Dal Pan, 2019, Annals of Internal Medicine.

Empirical assessment of case‐based methods for identification of drugs associated with acute liver injury in the French National Healthcare System database (SNDS)

J. Benichou, J. Rassen, J. Gagne, 2020, Pharmacoepidemiology and drug safety.

Empirical assessment of case-based methods for identification of drugs associated with upper gastrointestinal bleeding in the French National Healthcare System database (SNDS).

J. Benichou, J. Rassen, J. Gagne, 2020, Pharmacoepidemiology and drug safety.

The Schools Partnership Project : A Successful Model towards Improving School Performance

J. Rassen, Nita Winter, Ira Nowinski, 2012 .

Cardiovascular Outcomes and Mortality in Patients Using Clopidogrel With Proton Pump Inhibitors After Percutaneous Coronary Intervention or Acute Coronary Syndrome

Sebastian Schneeweiss, Jerry Avorn, Niteesh K. Choudhry, 2009, Circulation.

Understanding Bias Amplification

Sebastian Schneeweiss, Robert J. Glynn, Krista F. Huybrechts, 2011 .

Active safety monitoring of newly marketed medications in a distributed data network: application of a semi-automated monitoring system

Sebastian Schneeweiss, Robert J. Glynn, Gayathri Sridhar, 2012, Clinical pharmacology and therapy.

Optimal matching ratios in drug safety surveillance.

J. Rassen, S. Schneeweiss, Shirley V. Wang, 2014, Epidemiology.

Myers et al. Respond to “Understanding Bias Amplification”

Jessica A. Myers, Sebastian Schneeweiss, Robert J. Glynn, 2011 .

Visualizations throughout pharmacoepidemiology study planning, implementation, and reporting

J. Rassen, S. Schneeweiss, A. Bate, 2022, Pharmacoepidemiology and drug safety.

Actionable Real-World Evidence to Improve Health Outcomes and Reduce Medical Spending Among Risk-Stratified Patients with Diabetes.

J. Rassen, S. Schneeweiss, S. Jan, 2019, Journal of managed care & specialty pharmacy.

The comparative safety of opioids for nonmalignant pain in older adults.

J. Rassen, S. Schneeweiss, R. Glynn, 2011, Archives of internal medicine.

Applying propensity scores estimated in a full cohort to adjust for confounding in subgroup analyses

J. Rassen, S. Schneeweiss, K. Rothman, 2012, Pharmacoepidemiology and drug safety.

An Event‐Based Approach for Comparing the Performance of Methods for Prospective Medical Product Monitoring

Jeremy A Rassen, Sebastian Schneeweiss, Joshua J Gagne, 2012, Pharmacoepidemiology and drug safety.

One‐to‐many propensity score matching in cohort studies

Abhi Shelat, J. Myers, J. Rassen, 2012, Pharmacoepidemiology and drug safety.

Metrics for covariate balance in cohort studies of causal effects

Jeremy A Rassen, Sebastian Schneeweiss, Jessica M Franklin, 2014, Statistics in medicine.

Association of SARS-CoV-2 Seropositive Antibody Test With Risk of Future Infection

J. Rassen, D. Lowy, N. Sharpless, 2021, JAMA internal medicine.

Design considerations in an active medical product safety monitoring system

Malcolm Maclure, Sengwee Toh, Jeremy A Rassen, 2012, Pharmacoepidemiology and drug safety.

Do observational studies using propensity score methods agree with randomized trials? A systematic comparison of studies on acute coronary syndromes.

T. Trikalinos, J. Paulus, J. Rassen, 2012, European heart journal.

The comparative safety of analgesics in older adults with arthritis.

J. Rassen, S. Schneeweiss, R. Glynn, 2010, Archives of internal medicine.

American Journal of Epidemiology Practice of Epidemiology Instrumental Variable Analysis for Estimation of Treatment Effects with Dichotomous Outcomes

M Alan Brookhart, Jeremy A Rassen, Sebastian Schneeweiss, 2022 .

Measuring prevalence and incidence of chronic conditions in claims and electronic health record databases

Jeremy A Rassen, Sebastian Schneeweiss, J. Rassen, 2018, Clinical epidemiology.

Early Steps in the Development of a Claims-Based Targeted Healthcare Safety Monitoring System and Application to Three Empirical Examples

J. Avorn, J. Rassen, J. Gagne, 2012, Drug Safety.

Durability of the Single-Dose Ad26.COV2.S Vaccine in the Prevention of COVID-19 Infections and Hospitalizations in the US Before and During the Delta Variant Surge

J. Rassen, S. Schneeweiss, T. Kamath, 2022, JAMA network open.

Assessing the Comparative Effectiveness of Newly Marketed Medications: Methodological Challenges and Implications for Drug Development

R J Glynn, J. Rassen, J. Gagne, 2011, Clinical pharmacology and therapeutics.

Plasmode simulation for the evaluation of pharmacoepidemiologic methods in complex healthcare databases

Jennifer M. Polinski, Sebastian Schneeweiss, Jessica M. Franklin, 2014, Comput. Stat. Data Anal..

Reporting to Improve Reproducibility and Facilitate Validity Assessment for Healthcare Database Studies V1.0.

Olaf Klungel, Rosa Gini, Jeffrey Brown, 2017, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

High‐dimensional propensity scores for empirical covariate selection in secondary database studies: Planning, implementation, and reporting

J. Rassen, S. Schneeweiss, A. Pottegård, 2022, Pharmacoepidemiology and drug safety.

Effectiveness of the Single-Dose Ad26.COV2.S COVID Vaccine

J. Rassen, T. Kamath, J. Polinski, 2021, medRxiv.

Variable Selection for Confounding Adjustment in High-dimensional Covariate Spaces When Analyzing Healthcare Databases

Sebastian Schneeweiss, Jessica M Franklin, Wesley Eddings, 2017, Epidemiology.

High‐dimensional propensity score algorithm in comparative effectiveness research with time‐varying interventions

Romain Neugebauer, Julie A Schmittdiel, Zheng Zhu, 2015, Statistics in medicine.

Using high‐dimensional propensity scores to automate confounding control in a distributed medical product safety surveillance system

Sebastian Schneeweiss, J. Rassen, S. Schneeweiss, 2012, Pharmacoepidemiology and drug safety.

Real‐world evidence of bariatric surgery and cardiovascular benefits using electronic health records data: A lesson in bias

J. Rassen, S. Schneeweiss, W. Murk, 2020, Diabetes, obesity & metabolism.

Adjuvant vancomycin for antibiotic prophylaxis and risk of Clostridium difficile infection after coronary artery bypass graft surgery.

J. Rassen, J. Gagne, S. Schneeweiss, 2013, The Journal of thoracic and cardiovascular surgery.

Study design for a comprehensive assessment of biologic safety using multiple healthcare data systems

Jeffrey R Curtis, Kevin Haynes, Daniel H Solomon, 2011, Pharmacoepidemiology and drug safety.

The Role of Real‐World Evidence in FDA‐Approved New Drug and Biologics License Applications

J. Rassen, E. Garry, A. Case, 2021, Clinical pharmacology and therapeutics.

Real‐World Evidence for Assessing Pharmaceutical Treatments in the Context of COVID‐19

J. Rassen, S. Schneeweiss, R. Glynn, 2021, Clinical pharmacology and therapeutics.

Near-Real-Time Monitoring of New Drugs: An Application Comparing Prasugrel Versus Clopidogrel

Jun Liu, Jeremy A Rassen, Sebastian Schneeweiss, 2014, Drug Safety.

Type of stress ulcer prophylaxis and risk of nosocomial pneumonia in cardiac surgical patients: cohort study

J. Rassen, J. Gagne, S. Schneeweiss, 2013, BMJ : British Medical Journal.

Diagnosis-wide analysis of COVID-19 complications: an exposure-crossover study

J. Rassen, M. Fralick, W. Murk, 2020, Canadian Medical Association Journal.

Reporting to Improve Reproducibility and Facilitate Validity Assessment for Healthcare Database Studies V1.0

Olaf Klungel, Rosa Gini, Liam Smeeth, 2017, Pharmacoepidemiology and drug safety.

Incorporating Linked Healthcare Claims to Improve Confounding Control in a Study of In-Hospital Medication Use

J. Rassen, S. Schneeweiss, J. Franklin, 2015, Drug Safety.

Safety and effectiveness of bivalirudin in routine care of patients undergoing percutaneous coronary intervention.

J. Rassen, S. Schneeweiss, R. Glynn, 2010, European heart journal.

Coronary heart disease Safety and effectiveness of bivalirudin in routine care of patients undergoing percutaneous coronary intervention

J. Rassen, S. Schneeweiss, R. Glynn, 2010 .

Supplementing claims data with outpatient laboratory test results to improve confounding adjustment in effectiveness studies of lipid-lowering treatments

J. Avorn, J. Myers, J. Rassen, 2012, BMC Medical Research Methodology.

Effects of expanding the look‐back period to all available data in the assessment of covariates

J. Rassen, J. Franklin, Sonja S Nakasian, 2017, Pharmacoepidemiology and drug safety.

Maximum potential benefit of implantable defibrillators in preventing sudden death after hospital admission because of heart failure

J. Rassen, S. Schneeweiss, L. Stevenson, 2009, Canadian Medical Association Journal.

Evaluating the Validity of an Instrumental Variable Study of Neuroleptics: Can Between-Physician Differences in Prescribing Patterns Be Used to Estimate Treatment Effects?

J. Rassen, S. Schneeweiss, Philip S. Wang, 2007, Medical care.

Renin-Angiotensin-Aldosterone-System inhibitor use in patients with COVID-19 infection and prevention of serious events: a cohort study in commercially insured patients in the US

J. Rassen, S. Schneeweiss, S. Leonard, 2020, medRxiv.

Privacy-Maintaining Propensity Score-Based Pooling of Multiple Databases Applied to a Study of Biologics

Jeremy A Rassen, Daniel H Solomon, Jeffrey R Curtis, 2010, Medical care.

Comparative Effectiveness of Preventative Therapy for Venous Thromboembolism After Coronary Artery Bypass Graft Surgery

J. Myers, J. Rassen, J. Gagne, 2012, Circulation. Cardiovascular interventions.

Selective Serotonin Reuptake Inhibitor Use and Perioperative Bleeding and Mortality in Patients Undergoing Coronary Artery Bypass Grafting: A Cohort Study

J. Rassen, J. Gagne, S. Schneeweiss, 2015, Drug Safety.

Real-world data suggest antibody positivity to SARS-CoV-2 is associated with a decreased risk of future infection

J. Rassen, D. Lowy, N. Sharpless, 2020, medRxiv.

Scalable Feature Engineering from Electronic Free Text Notes to Supplement Confounding Adjustment of Claims‐Based Pharmacoepidemiologic Studies

Joseph M. Plasek, J. Rassen, S. Schneeweiss, 2022, Clinical pharmacology and therapeutics.

Single-arm oncology trials and the nature of external controls arms.

J. Rassen, S. Schneeweiss, M. Hashmi, 2021, Journal of comparative effectiveness research.

Prospective Cohort Studies of Newly Marketed Medications: Using Covariate Data to Inform the Design of Large-Scale Studies

J. Rassen, S. Schneeweiss, J. Franklin, 2014, Epidemiology.

COVID-19 Evidence Accelerator: A parallel analysis to describe the use of Hydroxychloroquine with or without Azithromycin among hospitalized COVID-19 patients

Carson K. Lam, G. Tourassi, J. Rassen, 2021, PloS one.

Newly marketed medications present unique challenges for nonrandomized comparative effectiveness analyses.

J. Rassen, S. Schneeweiss, 2012, Journal of comparative effectiveness research.

Confounding Adjustment in Comparative Effectiveness Research Conducted Within Distributed Research Networks

Bruce H Fireman, Sengwee Toh, Jeremy A Rassen, 2013, Medical care.

Confronting “confounding by health system use” in Medicare Part D: comparative effectiveness of propensity score approaches to confounding adjustment

J. Rassen, S. Schneeweiss, R. Glynn, 2012, Pharmacoepidemiology and drug safety.

A Painful Setback: Misinterpretation of Analgesic Safety in Older Adults May Inadvertently Worsen Pain Care—Reply

J. Rassen, S. Schneeweiss, R. Glynn, 2011 .

Erratum: High-dimensional Propensity Score Adjustment in Studies of Treatment Effects Using Health Care Claims Data.

J. Rassen, S. Schneeweiss, B. Fireman, 2018, Epidemiology.

Real-World Tumor Response of Palbociclib in Combination With an Aromatase Inhibitor as First-Line Therapy in Pre/Perimenopausal Women With Metastatic Breast Cancer

J. Rassen, S. Schneeweiss, N. Robert, 2023, Targeted Oncology.

Active Safety Monitoring of New Medical Products Using Electronic Healthcare Data: Selecting Alerting Rules

Jeremy A Rassen, Sebastian Schneeweiss, Joshua J Gagne, 2012, Epidemiology.

Multivariate‐adjusted pharmacoepidemiologic analyses of confidential information pooled from multiple health care utilization databases

Sebastian Schneeweiss, Jerry Avorn, Jeremy A. Rassen, 2010, Pharmacoepidemiology and drug safety.

Using Real-World Data to Predict Clinical and Economic Benefits of a Future Drug Based on its Target Product Profile

J. Rassen, C. Gerlinger, R. Wyss, 2020, Drugs - Real World Outcomes.

Reporting to Improve Reproducibility and Facilitate Validity Assessment for Healthcare Database Studies V1.0.

L. Smeeth, J. Rassen, J. Gagne, 2017, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Cardiovascular Outcomes and Mortality in Patients Using Clopidogrel With Proton Pump Inhibitors After Percutaneous Coronary Intervention or Acute Coronary Syndrome

J. Avorn, J. Rassen, S. Schneeweiss, 2009, Circulation.

Metrics for covariate balance in cohort studies of causal effects

J. Rassen, S. Schneeweiss, J. Franklin, 2014, Statistics in medicine.

Effects of adjusting for instrumental variables on bias and precision of effect estimates.

J. Myers, J. Rassen, J. Gagne, 2011, American journal of epidemiology.

Using high‐dimensional propensity scores to automate confounding control in a distributed medical product safety surveillance system

J. Rassen, S. Schneeweiss, 2012, Pharmacoepidemiology and drug safety.

Transparency and Reproducibility of Observational Cohort Studies Using Large Healthcare Databases.

JA Rassen, J. Rassen, A. Patrick, 2016, Clinical pharmacology and therapeutics.

Practice of Epidemiology Instrumental Variable Analysis for Estimation of Treatment Effects With Dichotomous Outcomes

J. Rassen, S. Schneeweiss, R. Glynn, 2009 .

Letter to the editor

J. Rassen, S. Schneeweiss, 2011 .

Multivariate‐adjusted pharmacoepidemiologic analyses of confidential information pooled from multiple health care utilization databases

J. Avorn, J. Rassen, S. Schneeweiss, 2010, Pharmacoepidemiology and drug safety.

High-dimensional Propensity Score Adjustment in Studies of Treatment Effects Using Health Care Claims Data

J. Avorn, J. Rassen, S. Schneeweiss, 2009, Epidemiology.

Re: Confounding adjustment via a semi-automated high-dimensional propensity score algorithm: an application to electronic medical records.

J. Rassen, S. Schneeweiss, 2011, Pharmacoepidemiology and drug safety.

Reply to the Letter by Arterburn D. et al. ("Bias in EHR‐based studies: Seeing the Forest for the Trees")

J. Rassen, S. Schneeweiss, W. Murk, 2021, Diabetes, obesity & metabolism.